XENE - Xenon Pharmaceuticals Inc.
43.05
-0.740 -1.719%
Share volume: 1,127,122
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$43.79
-0.74
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 02-27-2025 | 05-12-2025 | 08-11-2025 | 11-03-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 919.023 M | 884.011 M | 835.901 M | 798.139 M | 743.280 M | 674.281 M | 607.836 M | 633.163 M | |
| Current Assets | 707.204 M | 728.089 M | 659.639 M | 635.264 M | 565.537 M | 500.252 M | 480.137 M | 560.649 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 640.706 M | 584.801 M | 566.394 M | 484.193 M | 432.972 M | 352.164 M | 357.754 M | 349.723 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 58.896 M | 136.734 M | 87.621 M | 142.712 M | 116.657 M | 135.381 M | 104.514 M | 199.163 M | |
| Total Non-current Assets | 185.836 M | 129.062 M | 149.317 M | 127.496 M | 141.498 M | 137.297 M | 92.988 M | 37.152 M | |
| Property Plant Equipment | 9.393 M | 10.138 M | 10.162 M | 10.278 M | 9.696 M | 9.205 M | 8.887 M | 8.721 M | |
| Other Assets | 202.426 M | 145.784 M | 166.100 M | 152.597 M | 168.047 M | 164.824 M | 118.812 M | 63.793 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 919.023 M | 884.011 M | 835.901 M | 798.139 M | 743.280 M | 674.281 M | 607.836 M | 633.163 M | |
| Total liabilities | 31.325 M | 39.964 M | 38.094 M | 43.236 M | 39.323 M | 40.303 M | 48.325 M | 51.403 M | |
| Total current liabilities | 22.223 M | 31.285 M | 29.695 M | 35.590 M | 32.030 M | 33.047 M | 38.335 M | 41.792 M | |
| Accounts Payable | 20.900 M | 29.931 M | 28.308 M | 34.221 M | 30.648 M | 31.588 M | 36.840 M | 40.260 M | |
| Other liabilities | 9.102 M | 8.679 M | 8.399 M | 7.646 M | 7.293 M | 7.256 M | 9.990 M | 9.611 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 9.102 M | 8.679 M | 8.399 M | 7.646 M | 7.293 M | 7.256 M | 9.990 M | 9.611 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 887.698 M | 844.047 M | 797.807 M | 754.903 M | 703.957 M | 633.978 M | 559.511 M | 581.760 M | |
| Common stock | 1.603 B | 1.617 B | 1.630 B | 1.656 B | 1.669 B | 1.683 B | 1.699 B | 1.827 B | |
| Retained earnings | -713.071 M | -770.995 M | -833.785 M | -899.470 M | -964.517 M | -1.049 B | -1.140 B | -1.245 B |